Regional Commercial Management Organization

Your regional commercial partner for business growth across Emerging Markets

STRATLINKS is your outsourced regional commercial office. We plan your market entry, select and govern your distributors, and represent your interests across the focus markets — so you can grow here without building permanent regional infrastructure.

Start a conversation → See what we do →
Dubai — the STRATLINKS regional hub
$24.6B → $35BMENA medtech market · 2025–2032 growth
14Focus markets within Emerging Markets
1Regional partner · zero fixed office cost

01 · Who We Are

Not a distributor. Your outsourced regional commercial office.

STRATLINKS is a Regional Commercial Management Organization (RCMO) built for global medical device manufacturers entering or scaling across Emerging Markets. We are not a distributor and we do not take title to product.

We are the team that plans your market entry, selects and governs your distributors, and represents your interests across the region — so you can grow here without building permanent regional infrastructure.

“Our incentives sit entirely on your side of the table, shaped by your outcomes, never by channel margin.”
STRATLINKS — regional commercial governance

The Challenge We Solve

The same problems, market after market

Manufacturers entering Emerging Markets typically face the same set of problems. STRATLINKS exists to solve exactly this — bringing the regional commercial discipline of an in-house office, without the fixed cost, hiring risk or multi-year commitment.

01

Opportunistic distributor networks

Appointed by chance rather than strategy, with inconsistent performance and no shared KPIs.

02

Unreliable forecasting

No regional demand visibility to support production and supply chain planning.

03

Fragmented regulatory pathways

Multitude markets with a mosaic of Healthcare landscapes. No local hire can navigate all of them alone.

04

No local leadership

When no one is empowered to represent you, the result is weak market access and execution — leading to lost revenue.

02 · What We Do

The full commercial lifecycle with one partner. Your commercial arm.

Our service portfolio spans from first market entry to long-term regional governance.

03 · How We Work

A consistent, proven methodology

Every STRATLINKS engagement follows the same proprietary delivery framework — from first conversation to regional scale.

01

Discover

Understand your products, ambitions and constraints.

Design

Design a market-specific strategy.

Link

Identify and appoint the right partners.

Build

Stand up governance and reporting.

Execute

Drive commercial execution.

Optimize

Continuously improve performance.

Scale

Expand coverage market by market.

01

Discover

Understand your products, ambitions and constraints.

02

Design

Design a market-specific strategy.

03

Link

Identify and appoint the right partners.

04

Build

Stand up governance and reporting.

05

Execute

Drive commercial execution.

06

Optimize

Continuously improve performance.

07

Scale

Expand coverage market by market.

04 · The Market Opportunity

Growth, combined with structural underinvestment

The Emerging Markets we serve are among the few medical devices, implantable, equipment and consumable markets combining above-average growth with structural underinvestment in commercial infrastructure.

$24.6B → $35BMENA medical device market, 2025–2032 (5.1% CAGR)
$5.5B–$6.2BGCC devices & IVD market, 2026 estimate
~52% / 28%Saudi Arabia / UAE share of GCC medtech spend
18.2% CAGRGCC connected devices & wearables, 2026–2032

    Sources: Fortune Business Insights, MarketDataForecast, BioNixus GCC Medical Devices Report, MarkNtel Advisors (2025–2026 publications). Figures vary by methodology and are presented as directional ranges.

    What's driving it

    Government-led healthcare transformation

    Saudi Vision 2030, the UAE Digital Health Strategy and Qatar's National Health Strategy are expanding hospital capacity and increasing number of beds while tightening procurement standards.

    Chronic disease & demographic load

    Rising cardiovascular disease, diabetes and orthopedic conditions are expanding demand across monitoring, diagnostic and implantable categories.

    Regulatory fragmentation

    SFDA, MOHAP/DHA/DOH, NHRA and MOPH each run distinct registration pathways across the region.

    Private capital inflow

    Roughly 400 GCC healthcare financial transactions in under four years signal active private equity and strategic interest.

    05 · Who We Serve

    Built for how different manufacturers enter the region

    Multiple profiles, each with a distinct pain point — and a natural first service.

    Medical technology across Emerging Markets
    01 / 07

    European SMEs

    Profile & pain point

    Strong, CE-marked product with no MEA commercial footprint; too small to justify a regional office, but need credible in-market representation fast.

    Primary entry service

    Market Entry StrategyDistributor Search

    US & venture-backed innovators

    Profile & pain point

    FDA-cleared and capital-efficient by mandate. The board wants regional revenue proof points without regional headcount.

    Primary entry service

    Market Entry AssessmentFractional Regional Management

    Japanese & Korean manufacturers

    Profile & pain point

    Technically excellent, methodical and relationship-driven; need a trusted intermediary who operates to their governance standards.

    Primary entry service

    Distributor GovernanceCommercial Excellence

    Premium Asian manufacturers

    Profile & pain point

    Increasingly capable product, but a regional credibility gap; need third-party governance to reassure hospital buyers.

    Primary entry service

    Distributor GovernanceMarket IntelligenceFractional Regional Management

    Private equity portfolio companies

    Profile & pain point

    The sponsor wants regional growth proof for the next raise or exit within a defined hold period — and Capex for a regional office is off the table.

    Primary entry service

    Market Entry StrategyExecutive Representation

    Manufacturers with legacy distributors

    Profile & pain point

    An existing network that's underperforming, opaque or misaligned, with no local visibility to fix it directly.

    Primary entry service

    Distributor Governance & TurnaroundFractional Regional Management

    Digital health & connected devices

    Profile & pain point

    The fastest-growing sub-segment (~18% CAGR); asset-light teams with no experience in physical distribution or market access.

    Primary entry service

    Market Entry StrategyDistributor Search

    06 · Why STRATLINKS

    Aligned with you, built for your business

    Compared with the alternatives

    The alternativeWhat it offersWhere STRATLINKS wins

    In-house regional office

    Scale & control

    Full control, dedicated headcount.

    A fraction of the fixed cost; operational from month one; no hiring or visa risk.

    Distributor / commercial agent

    Local relationships

    Immediate market access, local relationships.

    No channel conflict; you retain commercial control and IP over the relationship.

    Global management consultancy

    Board-level framing

    Strategic credibility, brand recognition.

    Ongoing accountability and execution, not a report; regional MedTech specialization.

    Generalist CSO (pharma-oriented)

    Field deployment

    Field rep deployment, sales infrastructure.

    Purpose-built for MedTech distributor governance, not headcount deployment.

    One partner, purpose-built for MedTech — accountable for both the thinking and the execution across your Emerging Markets footprint.

    07 · Engagement Models

    Structured around where you are — not one-size-fits-all

    Test the market

    A market entry assessment, a distributor search, or launch planning for a single country.

    Commit to the region

    Ongoing governance, reporting and representation across one or several markets, scaled to your footprint.

    Senior regional presence

    Fractional executive representation for manufacturers who need seniority in-market without a full-time regional hire.

    Every engagement begins with a scoping conversation to understand your product, current regional footprint and growth ambitions. We recommend the model that fits — not the model that maximizes our fee.

    Let's Talk

    Evaluating how to enter, expand or fix your commercial presence in Emerging Markets?

    We would welcome a conversation about your specific market and product category.

    Email us → Connect on LinkedIn →